nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Availability of genome-matched therapy based on clinical practice
|
Hayashi, Naomi |
|
|
29 |
7 |
p. 964-971 |
artikel |
2 |
Biomarker-oriented chemo-immunotherapy for advanced gastric cancer
|
Kono, Koji |
|
|
29 |
7 |
p. 865-872 |
artikel |
3 |
Clinicopathological characteristics of Lynch-like syndrome
|
Nakamori, Sakiko |
|
|
29 |
7 |
p. 944-952 |
artikel |
4 |
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology
|
Najima, Yuho |
|
|
29 |
7 |
p. 899-910 |
artikel |
5 |
Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer
|
Fukushima, Ryosuke |
|
|
29 |
7 |
p. 1002-1011 |
artikel |
6 |
Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome
|
Ito, Tetsuya |
|
|
29 |
7 |
p. 953-963 |
artikel |
7 |
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis
|
Iihara, Hirotoshi |
|
|
29 |
7 |
p. 873-888 |
artikel |
8 |
Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy
|
Kawai, Kazushige |
|
|
29 |
7 |
p. 1012-1018 |
artikel |
9 |
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023
|
Kobayashi, Masamitsu |
|
|
29 |
7 |
p. 889-898 |
artikel |
10 |
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of elranatamab for multiple myeloma, CPX-351 for myeloid leukemia, inotuzumab ozogamicin for lymphoblastic leukemia, capivasertib for breast cancer, and zolbetuximab for gastric cancer in Japan
|
Matsumura, Noriomi |
|
|
29 |
7 |
p. 863-864 |
artikel |
11 |
Preoperative predictive factors for positive peritoneal cytology results in patients with pancreatic ductal adenocarcinomas: a retrospective study
|
Shimane, Gaku |
|
|
29 |
7 |
p. 985-993 |
artikel |
12 |
Relationship between HER2-low status and efficacy of CDK4/6 inhibitors in advanced breast cancer: a real-world study
|
Önder, T. |
|
|
29 |
7 |
p. 972-984 |
artikel |
13 |
Risk factors for lymph node metastasis in T2 colorectal cancer: a systematic review and meta-analysis
|
Watanabe, Jun |
|
|
29 |
7 |
p. 921-931 |
artikel |
14 |
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
|
Hiraizumi, Kenji |
|
|
29 |
7 |
p. 932-943 |
artikel |
15 |
Short- and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis
|
Xue, Guoqiang |
|
|
29 |
7 |
p. 1035-1043 |
artikel |
16 |
Significance of radiation therapy in the myxoid round-cell liposarcoma treatment regimen
|
Shimatani, Akiyoshi |
|
|
29 |
7 |
p. 1044-1051 |
artikel |
17 |
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy
|
Numakura, Kazuyuki |
|
|
29 |
7 |
p. 1019-1026 |
artikel |
18 |
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study
|
Sato, Sho |
|
|
29 |
7 |
p. 994-1001 |
artikel |
19 |
Trends in incidence and hormonal management of endometrial cancer during potentially reproductive age in Japan: a population-based study
|
Sasano, Tomoyuki |
|
|
29 |
7 |
p. 1027-1034 |
artikel |
20 |
Trends in the surgical treatment for metastatic spinal tumor in Japanese administrative data between 2012 and 2020
|
Yamada, Kentaro |
|
|
29 |
7 |
p. 911-920 |
artikel |